Inventor · disambiguated record
Curt D. Wolfgang
Also filed as: WOLFGANG CURT · WOLFGANG CURT D · WOLFGANG CURT DOUGLAS
19 granted patents·21 pending applications·105 citations·filing 2000–2023
94Inventor score
Top patents by PatentIndex Score
40 records- 0194US10272076B2Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2017·Granted Apr 30, 2019·9 cites·20 claims
- 0293US9138432B2Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·12 cites·1 claims
- 0393US8586610B2Methods for the administration of iloperidoneWOLFGANG CURT D·Filed 2005·Granted Nov 19, 2013·25 cites·16 claims
- 0492US10987346B2Iloperidone for the treatment of schizophreniaVANDA PHARMACEUTICALS INC·Filed 2019·Granted Apr 27, 2021·4 cites·13 claims
- 0589US9157121B2Method of treatment based on polymorphisms of the KCNQ1 geneVANDA PHARMACEUTICALS INC·Filed 2015·Granted Oct 13, 2015·7 cites·15 claims
- 0687US2023330078A1Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0785US11707474B2Methods for treating acute myeloid leukemia and related conditionsGLYCOMIMETICS INC·Filed 2019·Granted Jul 25, 2023·3 cites·57 claims
- 0884US10874659B2Iloperidone metabolite for use in the treatment of psychiatric disordersVANDA PHARMACEUTICALS INC·Filed 2013·Granted Dec 29, 2020·6 cites·7 claims
- 0984US10441580B2Iloperidone for the treatment of schizophreniaVANDA PHARMACEUTICALS INC·Filed 2016·Granted Oct 15, 2019·4 cites·20 claims
- 1083US8999638B2Method of treatment based on polymorphisms of the KCNQ1 geneWOLFGANG CURT D·Filed 2010·Granted Apr 7, 2015·6 cites·15 claims
- 1182US10563259B2Method of treatment based on polymorphisms of the KCNQ1 geneVANDA PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·2 cites·11 claims
- 1282US7052703B1T-cell receptorγ alternate reading frame protein, (TARP) and uses thereofUS HEALTH·Filed 2000·Granted May 30, 2006·9 cites·31 claims
- 1380US9446038B2Method and composition for treating a serotonin receptor-mediated conditionVANDA PHARMACEUTICALS INC·Filed 2013·Granted Sep 20, 2016·3 cites·10 claims
- 1480US8618134B2Method and composition for treating a serotonin receptor-mediated conditionPOLYMEROPOULOS MIHAEL H·Filed 2008·Granted Dec 31, 2013·4 cites·19 claims
- 1579US8729100B2Method and composition for treating an alpha adrenoceptor-mediated conditionPOLYMEROPOULOS MIHAEL H·Filed 2008·Granted May 20, 2014·4 cites·12 claims
- 1678US2024016791A1Iloperidone metabolite for use in the treatment of psychiatric disordersVANDA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1777US2021186948A1Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1873US2020206213A1Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1970US7732134B2Methods to predict cholesterol elevation during immunosuppressant therapyNOVARTIS AG·Filed 2003·Granted Jun 8, 2010·7 cites·3 claims
- 2070US2019183873A1Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2168US2023414641A1Methods for treating acute myeloid leukemia and related conditionsGLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 2265US2021015809A1Iloperidone metabolite for use in the treatment of psychiatric disordersVANDA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2365US2014045893A1Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2464US2010063093A1Methods for the administration of iloperidoneWOLFGANG CURT·Filed 2008·Application pending·0 cites
- 2564US2024139196A1Combination treatments in difficult to treat patients with advanced and/or metastatic trop-2 overexpressing cancersG1 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2663US2019360047A1Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2761US7897355B2Gene expressed in prostate cancer and methods of useUS HEALTH·Filed 2008·Granted Mar 1, 2011·0 cites·17 claims
- 2860US2014039008A1Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2959US2015258083A1Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3058US10272075B2Method and composition for treating an alpha adrenoceptor-mediated conditionVANDA PHARMACEUTICALS INC·Filed 2014·Granted Apr 30, 2019·0 cites·13 claims
- 3158US9987264B2Method and composition for treating a serotonin receptor-mediated conditionVANDA PHARMACEUTICALS INC·Filed 2016·Granted Jun 5, 2018·0 cites·14 claims
- 3252US7816087B2Gene expressed in prostate cancer and methods of useUS HEALTH·Filed 2002·Granted Oct 19, 2010·0 cites·9 claims
- 3352US2016053324A1Methods for the administration of iloperidoneVANDA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3452US2015368718A1Method of treatment based on polymorphisms of the kcnq1 geneVANDA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3547US2007248955A1Use Of Genetic Polymorphisms To Predict Drug-Induced HepatotoxicityNOVARTIS AG·Filed 2004·Application pending·0 cites
- 3647US2007289889A1Biomarkers For The Prediction Of Drug-In Duced DiarrheaNOVARTIS AG·Filed 2004·Application pending·0 cites
- 3745US2009306137A1Treatment for depressive disordersWOLFGANG CURT D·Filed 2007·Application pending·0 cites
- 3842US2008033053A1Cross-Reference To Related ApplicationsWOLFGANG CURT D·Filed 2005·Application pending·0 cites
- 3942US2010184798A1Methods to Predict Cholesterol Elevations during Immunosuppressant TherapyKUDARAVALLI SRIDHAR·Filed 2010·Application pending·0 cites
- 4039US2006008804A1Marker genesCHIBOUT SALAH-DINE·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →